CCT5P1

Across TCGA pan-cancer cohorts, CCT5P1 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of CCT5P1’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where CCT5P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CCT5P1 is over-expressed in tumor.

BLCA, LUAD, and KIRC are the cancer types where CCT5P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CCT5P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.126	<.001	10	view →
LUAD	All	All	+0.139	<.001	7	view →
KIRC	All	All	+0.034	<.001	7	view →
HNSC	Male	All	+0.098	<.001	6	view →
BRCA	All	II,III,IV	+0.071	<.001	6	view →
COAD	Female	II,III,IV	+0.355	<.001	5	view →
STAD	All	All	+0.127	.004	4	view →
LUSC	All	II,III,IV	+0.106	.001	4	view →
KIRP	Female	All	+0.054	.004	3	view →
PAAD	Male	All	+0.110	.031	2	view →
CHOL	All	All	+0.052	.033	2	view →
PRAD	All	All	+0.031	.024	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

CCT5P1–BLCA

Open the BLCA breakdown →